Home
October 2009 November 2009 December 2009
Su Mo Tu We Th Fr Sa
Week 45 1 2 3 4 5 6 7
Week 46 8 9 10 11 12 13 14
Week 47 15 16 17 18 19 20 21
Week 48 22 23 24 25 26 27 28
Week 49 29 30

Bladder Cancer
UroToday's Bladder Cancer section is a repository of the clinical publications, clinical trials and investigative science pertaining to the diagnosis and treatment of bladder cancer. Also available are conference coverage for all timely bladder cancer science, audio podcasts and downloadable slides from UroToday's slide library.
Online Urology & Urologic Oncology Journal
Please read about the UroToday International Journal; We welcome submissions year round and are committed to providing fast-tracked, peer reviewed publication.

Search    Display results per page
Results 1 - 50 of 1726
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
Beyond the Abstract - Synergistic potentiation of interferon activity with maitake mushroom D-fraction on bladder cancer cells, by Sensuke Konno, PhD, et al.
Friday, 06 November 2009
BERKELEY, CA (UroToday.com) - In this in vitro study, we demonstrated that growth inhibitory activity of interferon-α2b (IFN-α2b) on bladder cancer T24 cells was synergistically enhanced with maitake mushroom D-fraction (PDF), a bioactive extract.
Login to read more...

Cyclin-mediated G1 arrest by celecoxib differs in low-versus high-grade bladder cancer - Abstract
Friday, 06 November 2009
Department of Urology, William S. Middleton Memorial Veterans Hospital, and Department of Urology, University of Wisconsin School of Medicine and Public Health, Madison, WI 53792, USA.
read more

Survivin expression as a strong indicator of recurrence in urothelial bladder cancer. Predictive value of nuclear versus cytoplasmic staining - Abstract
Friday, 06 November 2009
Department of Cytopathology, Aretaieion University Hospital, Athens, Greece.
read more

The follow-up of patients with non-muscle-invasive bladder cancer by urine cytology, abdominal ultrasound and urine CYFRA 21-1: a pilot study - Abstract
Friday, 06 November 2009
Department of Oncology, Hadassah and Hebrew University Medical Centre, P.O. Box 12000, Jerusalem 91120, Israel.
read more

The role of surveillance in the treatment of patients with muscle-invasive bladder cancer after chemotherapy - Abstract
Friday, 06 November 2009
Department of Urology, University of California, Davis Medical Center, Sacramento, CA, USA.
read more

Beyond the Abstract - Laparoscopic radical cystectomy with vaginal specimen extraction: Case report, by Gonzalo Vitagliano, MD
Thursday, 05 November 2009
BERKELEY, CA (UroToday.com) - Laparsocopic radical cystectomy is still a novel procedure at our institution.
Login to read more...

Fibroblast growth factor receptor 3 mutation in voided urine is a useful diagnostic marker and significant indicator of tumor recurrence in non-muscle invasive bladder cancer - Abstract
Thursday, 05 November 2009
Oncogene Research Unit/Cancer Prevention Unit, Tochigi Cancer Center Research Institute, 4-9-13 Yonan, Utsunomiya, Japan.
read more

Sequence variant on 3q28 and urinary bladder cancer risk: Findings from the Los Angeles-Shanghai bladder case-control study - Abstract
Thursday, 05 November 2009
Department of Preventive Medicine, Keck School of Medicine, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California;
read more

Distinct microRNA alterations characterize high- and low-grade bladder cancer - Abstract
Thursday, 05 November 2009
Academic Urology Unit, University of Sheffield, Sheffield, United Kingdom.
read more

AUA NY 2009 - Management of non-muscle invasive bladder cancer: Use of 2007 AUA guidelines - Multimedia Presentation
Wednesday, 04 November 2009
SEWARD, AK, USA - Presented by Muhammad Choudhury, MD at the 107th Annual Meeting of the AUA - New York Section - August 19 - 26, 2009, Seward, Alaska, USA
Login to read more...

Beyond the Abstract - Non-invasive methods to detect schistosome-based bladder cancer: is the association sufficient for epidemiological use? by Clive Shiff, MD and Robert W. Veltri, MD
Wednesday, 04 November 2009
BERKELEY, CA (UroToday.com) - Urinary schistosomiasis caused by the trematode parasite Schistosoma haematobium is endemic in most of Africa.
Login to read more...

The D2 dopamine receptor gene and nicotine dependence among bladder cancer patients and controls - Abstract
Wednesday, 04 November 2009
Department of Epidemiology, Unit 1340, The University of Texas M. D. Anderson Cancer Center, 1155 Pressler Blvd. Unit 1340, Houston, TX, 77030, USA.
read more

Full analysis of the prostatic urethra at the time of radical cystoprostatectomy for bladder cancer: impact on final disease stage - Abstract
Wednesday, 04 November 2009
Department of Pathology, Pitie-Salpetriere Hospital, GHU Est, University PMC Paris VI, Paris, France.
read more

Randomized phase III trial on gemcitabine versus mytomicin in recurrent superficial bladder cancer: Evaluation of efficacy and tolerance - Abstract
Wednesday, 04 November 2009
Oncologica Operative Unit "S. Giovanni di Dio" Hospital, ASL Napoli3 Frattaminore; Department of Biochemistry and Biophysics, Second University of Naples, Via Costantinopoli; Unit of Urology, "Santa Maria La Pietà" Hospital, Casoria, Naples; and the Campus Biomedico University, Section of Oncology, Rome, Italy.
read more

Predictive Biosciences announces publication in Journal of Urology of results from a pilot study of its non-invasive assay to monitor patients for bladder cancer
Tuesday, 03 November 2009
LEXINGTON, MA, USA (Press Release) - November 3, 2009
read more

Therapeutic management of de novo urological malignancy in renal transplant recipients - Abstract
Tuesday, 03 November 2009
Department of Urology, Centre Hospitalo-Universitaire Pellegrin-Tripode, 33000, Bordeaux, France.
read more

Beyond the Abstract - Fibrin clot inhibitor medication and efficacy of Bacillus Calmette-Guerin for bladder urothelial cancer, by Stephen Boorjian, MD
Friday, 30 October 2009
BERKELEY, CA (UroToday.com) - Intravesical BCG is an immunotherapy that, together with endoscopic resection, represents the current gold standard treatment for patients with high risk non-muscle invasive urothelial carcinoma.
Login to read more...

Editorial - Is the incidence of uretero-intestinal anastomotic stricture increased in patients undergoing radical cystectomy with previous pelvic radiation?
Friday, 30 October 2009
BERKELEY, CA (UroToday.com) - In the online edition of the British Journal of Urology, the Department of Urology at the University of Miami reported on the impact of prior pelvic radiotherapy (XRT) on the occurrence of uretero-intestinal anastomosis (UIA) stricture at subsequent urinary diversion.
Login to read more...

BJUI Mini Reviews - Environmental factors involved in carcinogenesis of urothelial cell carcinomas of the upper urinary tract
Thursday, 29 October 2009
This review discusses the environmental factors, including tobacco use and occupational exposure, involved in upper urinary tract (UUT) carcinoma.
Login to read more...

Efficacy of Bacillus Calmette-Guerin (BCG) therapy and cauterization of the tumor versus BCG therapy without cauterization for superficial bladder cancer - Abstract
Thursday, 29 October 2009
Guilan University of Medical Sciences, Urology Research Center, Razi Hospital, Sardare Jangal Street, Rasht, Guilan 41448, Iran.
read more

Simultaneous penile and signet ring cell bladder carcinoma in renal transplant recipient: a first case - Abstract
Tuesday, 27 October 2009
Department of Surgery, Universityof Pisa, Italy.
read more

Lymphovascular invasion in transurethral resection specimens as predictor of progression and metastasis in patients with newly diagnosed T1 bladder urothelial cancer - Abstract
Tuesday, 27 October 2009
Urologic Oncology Clinic, Center for Specific Organs Cancer, National Cancer Center, Goyang, Korea.
read more

Upper urinary tract recurrence after radical cystectomy for bladder cancer-who is at risk? - Abstract
Tuesday, 27 October 2009
Department of Urology, University of Ulm, Ulm; Department of Urology, Klinikum Kassel, Kassel, Germany.
read more

The central urology multidisciplinary team - is it time to change the referral criteria? An audit of practice in a district general hospital in London - Abstract
Tuesday, 27 October 2009
All cancer patients are discussed in multidisciplinary team meetings (MDTs).
read more

Paraneoplastic production of heparin-like anticoagulant in a patient with metastatic transitional cell carcinoma - Abstract
Monday, 26 October 2009
Department of Urology, Columbia University College of Physicians & Surgeons, New York, NY.
read more

What is most important is what comes across : Urological guidelines from the target group's point of view - Abstract
Monday, 26 October 2009
Klinik für Urologie, Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Deutschland.
read more

Hexylaminolaevulinate fluorescence cystoscopy in patients previously treated with intravesical Bacille Calmette-Guérin - Abstract
Monday, 26 October 2009
The Urology Centre and Department of Histopathology, Guy's and St. Thomas' NHS Foundation Trust, London, UK.
read more

Arsenic exposure predicts bladder cancer survival in a US population - Abstract
Monday, 26 October 2009
Section of Biostatistics and Epidemiology, Department of Community and Family Medicine, Norris Cotton Cancer Center, Dartmouth Medical School, 7927 Rubin 860 One Medical Center Drive, Lebanon, NH, 03756, USA.
read more

Quadrimodal treatment of high-risk T1 and T2 bladder cancer: Transurethral tumor resection followed by concurrent radiochemotherapy and regional deep hyperthermia - Abstract
Monday, 26 October 2009
Department of Radiooncology, University of Erlangen, Germany.
read more

Glucocorticoid therapy and risk of bladder cancer - Abstract
Monday, 26 October 2009
Department of Community and Family Medicine, Dartmouth Medical School, Lebanon, NH 03756, USA
read more

AUA NY 2009 - Fluorescence cystoscopy for detection of initial and recurrent bladder cancer - Multimedia Presentation
Friday, 23 October 2009
SEWARD, AK, USA - Presented by Ihor S. Sawczuk, MD at the 107th Annual Meeting of the AUA - New York Section - August 19 - 26, 2009, Seward, Alaska, USA
Login to read more...

Methodology of superficial bladder cancer trials: objective evaluation of treatment - the need for standardization - Abstract
Friday, 23 October 2009
Università Cattolica S. Cuore, Policlinico A. Gemelli, Cattedra di Urologia, Rome, Italy.
read more

Prognostic significance of hydronephrosis in bladder cancer treated by radical cystectomy - Abstract
Friday, 23 October 2009
Department of Urology, Faculty of Medicine, University of Ankara, Ankara, Turkey.
read more

Intermediate-risk group in patients with transitional cell carcinoma of the bladder: prediction of high-risk patients in this heterogeneous group - Abstract
Friday, 23 October 2009
Department of Urology, Yeditepe University Medical Faculty, Istanbul, Turkey.
read more

Intermittent self-catheterization and the risk of squamous cell cancer of the bladder: An emerging clinical entity? - Abstract
Friday, 23 October 2009
Department of Urology and Pathology, St. Vincent's University Hospital, Elm Park, Dublin 4, Ireland.
read more

Differential diagnosis of overactive bladder in men - Abstract
Friday, 23 October 2009
State University of New York Downstate Medical School, Brooklyn and Weill Medical College of Cornell University and Lenox Hill Hospital, New York, New York.
read more

Composite paraganglioma-ganglioneuroma of the urinary bladder: a rare neoplasm causing hemodynamic crisis at tumour resection - Abstract
Friday, 23 October 2009
Department of Pathology and Molecular Medicine, Department of Urology, Department of Anesthesiology, Kingston General Hospital and Queen’s University, Kingston, ON.
read more

Clinical benefits of a multivariate prediction model for bladder cancer: a decision analytic approach - Abstract
Thursday, 22 October 2009
Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York.
read more

Vitamin E succinate induced apoptosis and enhanced chemosensitivity to paclitaxel in human bladder cancer cells in vitro and in vivo - Abstract
Thursday, 22 October 2009
Department of Urology, Keio University School of Medicine, Tokyo, Japan.
read more

Practice patterns and recurrence after partial cystectomy for bladder cancer - Abstract
Thursday, 22 October 2009
Department of Surgery (Urology), McGill University, Montreal, QC, Canada.
read more

Focal amplifications are associated with high-grade and recurrences in stage Ta bladder carcinoma - Abstract
Wednesday, 21 October 2009
Department of Genetics and Pathology, Rudbeck Laboratory, Uppsala University, SE-75185 Uppsala, Sweden.
read more

AUA NY 2009 - Detection of circulating tumor cells (CTC) - Multimedia Presentation
Tuesday, 20 October 2009
SEWARD, AK, USA - Presented by Nicholas Romas, MD at the 107th Annual Meeting of the AUA - New York Section - August 19 - 26, 2009, Seward, Alaska, USA
Login to read more...

Hexaminolevulinate is equal to 5-aminolevulinic acid concerning residual tumor and recurrence rate following photodynamic diagnostic assisted transurethral resection of bladder tumors - Abstract
Tuesday, 20 October 2009
Department of Urology, Caritas-St. Josef Medical Center, University of Regensburg, Regensburg, Germany.
read more

Aggregate lymph node metastasis diameter and survival after radical cystectomy for invasive bladder cancer - Abstract
Tuesday, 20 October 2009
Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio, USA.
read more

Bacillus calmette-guérin is superior to a combination of epirubicin and interferon-alpha2b in the intravesical treatment of patients with stage T1 urinary bladder cancer. A prospective, randomized, Nordic study - Abstract
Tuesday, 20 October 2009
Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University Hospital, Umeå, Sweden.
read more

WCE 2009 - Robotic extended pelvic lymphadenectomy for bladder cancer: Initial experience with greater nodal yield - Session Highlights
Monday, 19 October 2009
MUNICH, GERMANY (UroToday.com) - The role of regional lymphadenectomy during uro-oncologic surgery is no more clear than it is for bladder cancer.
Login to read more...

WCE 2009 - Open versus robot-assisted radical cystectomy: Comparison of early outcomes and cost - Session Highlights
Monday, 19 October 2009
MUNICH, GERMANY (UroToday.com) - The adoption of Robot-Assisted Laparoscopic Radical Prostatectomy (RALP) into the uro-oncologists armamentarium has been relatively rapid, particularly in the United States.
Login to read more...

Urinary fluorescence in situ hybridization assay for detecting urothelial carcinoma in Taiwanese patients - Abstract
Monday, 19 October 2009
Division of Urology, Department of Surgery, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
read more

Photodynamic diagnosis (5-aminolevulinic acid) of transitional cell carcinoma after bacillus Calmette-Guérin immunotherapy and mitomycin C intravesical therapy - Abstract
Monday, 19 October 2009
Department of Urology, University Medical Center Utrecht, Utrecht, The Netherlands.
read more

Evidence-based principles of bladder cancer and diet - Abstract
Monday, 19 October 2009
Division of Urology, Department of Surgery, University of California, San Diego Medical Center, San Diego, CA.
read more








Exclusive!

Interview on Clinical Practice Experience with NMP22

Meet the Expert

Meet the Expert - Mark S. Soloway

Meet the Expert - Ihor S. Sawczuk

Focus on Bladder Cancer

Focus on Bladder Cancer condenses a selection of compelling and relevant science - on topic and chosen by the UroToday.com editorial staff.



Urinary Bladder Cancer: Diffusion-Weighted MR Imaging--Accuracy for Diagnosing T Stage and Estimating Histologic Grade

- Beyond the Abstract

The Novel Use of Intravesical Docetaxel for the Treatment of Non-Muscle Invasive Bladder Cancer Refractory to BCG Therapy: A Single Institution Experience

- Editorial

Predictive Value of Telomerase Reverse Transcriptase Expression in Patients with High Risk Superficial Bladder Cancer Treated with Adjuvant BCG Immunotherapy

- Editorial

ImageTherapeutic Options in the Management of Intermediate-Risk Nonmuscle-Invasive Bladder Cancer

- BJUI Mini Reviews

Image

A Cost Comparison of the Diagnostic Modalities Used in the Detection of Urothelial Carcinoma in Patients Undergoing Evaluation for Hematuria

- UroToday International Journal

ImageTwo Centuries of Cystoscopy: The Development of Imaging, Instrumentation and Synergistic Technologies

- BJUI Mini Reviews

Clinical Outcome of Chemoradiotherapy for T1G3 Bladder Cancer

- Beyond the Abstract

Prognostic Significance of Nondiagnostic Molecular Changes in Urine Detected by UroVysion Fluorescence In Situ Hybridization During Surveillance for Bladder Cancer

- Editorial

Image

Utilization of the NMP22® BladderChek® Urine Test as an Adjunct to Atypical Cytology in the Detection of Bladder Cancer Recurrence

- UroToday International Journal

Radiation Therapy for Prostate Cancer Increases Subsequent Risk of Bladder and Rectal Cancer: A Population Based Cohort Study

- Editorial

Image

Long Term Clinical Outcome of a Phase I Trial of Intravesical Docetaxel in the Management of Superficial Bladder Cancer Refractory to Standard Intravesical Therapy

- UroToday International Journal

ImageInvestigation of Publication Bias Using the Model of p53 Accumulation in Bladder Cancer

- UroToday International Journal

Cultured Milk, Yogurt, and Dairy Intake in Relation to Bladder Cancer Risk in a Prospective Study of Swedish Women and Men

- Editorial

Adjuvant Methotrexate, Vinblastine, Adriamycin, and Cisplatin Chemotherapy has Potential to Prevent Recurrence of Bladder Tumors After Surgical Removal of Upper Urinary Tract Transitional Cell Carcinoma

- Editorial

Matrix Metalloproteinase Polymorphisms Are Associated with Bladder Cancer Invasiveness

- Editorial - Editor's Pick

Laparoscopic Radical Cystectomy for Cancer: Oncological Outcomes at up to 5 years

- Editorial - Editor's Pick

ImageBladder Cancer and the Aluminium Industry: A Review

- BJUI Mini Reviews

External Beam Radiation Therapy Followed by Interstitial Radiotherapy with Iridium-192 for Solitary Bladder Tumours: Results of 111 Treated Patients

- Beyond the Abstract

Bladder Tumor Markers: From Hematuria to Molecular Diagnostics - Where Do We Stand?

- Beyond the Abstract

Familial and Genetic Risk of Transitional Cell Carcinoma of the Urinary Tract

- Beyond the Abstract

Bladder-Sparing Therapy for Muscle-Infiltrating Bladder Cancer

- Beyond the Abstract

Detection of Bladder Cancer in Human Urine by Metabolomic Profiling Using High Performance Liquid Chromatography/Mass Spectrometry

- Beyond the Abstract

ImageInvasive T1 Bladder Cancer: Indications and Rationale for Radical Cystectomy

- BJUI Mini Reviews

Podcast - San Francisco Firefighters and Bladder Cancer Screening

- Podcast

ImagePredicting Survival After Radical Cystectomy for Bladder Cancer

- BJUI Mini Reviews







Bladder Cancer Screening

Improved Detection and Surveillance of Bladder Cancer Using a Point-of-Care NMP22 Assay

- by Mark S. Soloway, MD

Improving the Diagnosis of Bladder Cancer -Combining Cystoscopy with a Physician's Office Tumor Marker Test

- CME Training Program

Improved Detection of Bladder Cancer in Diagnosis and Surveillance Patients Using a Point-of-Care Proteomic Assay

- Barry Stein, MD on Improved Detection of Bladder Cancer in Diagnosis

Should We Screen for Bladder Cancer in a High Risk Population: A Cost per Life-Year Saved Analysis?

- Yair Lotan, MD on Screening for Bladder Cancer

Wisconsin Industrial Workers Might Be At Increased Risk For Bladder Cancer

- Giora Katz, MD Reports on Increased Risk for Bladder Cancer

Utility of NMP22 BladderCheck Point-Of-Care Assay In Evaluation Of Hematuria: A Multicenter Study

- Giora Katz, MD on the Utility of NMP22 Bladdercheck

Initial Diagnosis Of Bladder Cancer Using A Point-Of-Care Assay

- H. Barton Grossman, MD & the NMP22 Clinical Investigation Group




Bladder Cancer in Conferences


ImageAmerican Society of Clinical Oncology (ASCO) 2009 Annual Meeting

- View Bladder Cancer Session Highlights
ImageAmerican Urological Association (AUA) 2009 Annual Meeting

- View Bladder Cancer Session Highlights from the AUA 2009 Annual Meeting
Image10 Tips for Non-Muscle Invasive Bladder Cancer

- Lecture presented at WUF 2009 by David P. Wood, Jr., MD

ImageSociety of Urologic Oncology (SUO) 9th Annual Winter Meeting

- View Bladder Cancer Session Highlights

ImageRobot Assisted Radical Cystectomy: Is it Ready for Prime Time?

- Session Highlight from AUA Western Section 2008

ImageBladder Cancer Cytology and Markers in Diagnosis and Assessment

- Presentation from the 2008 AUA NY Meeting

Re-Staging Transurethral Resection: Who Benefits?

- Slide Presentation from the 2008 AUA NY Section Meeting

ImageNon-Muscle Invasive Transitional Cell Carcinoma

- Slide Presentation from the 2008 Masters in Urology Conference

American Society of Clinical Oncology 44th Annual Meeting

- Bladder Cancer Abstracts

The American Urological Association 2008 Annual Meeting

- Bladder Cancer Session Highlights

ImageEngineering and Urology Society 23rd Annual Meeting

- Bladder Cancer Abstracts

ImageEuropean Association of Urology 23rd Annual EAU Congress

- Bladder Cancer Session Highlights

 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
Results 1 - 50 of 1726

Member's Section

Login

Sign Up

Quick Search

Meet the Expert


All Experts


Featured Conference

Media and Publisher

Advertising Rates
Reprints

Working with Industry

Case Studies
Sponsorship Opportunities

Bladder Cancer
Sponsored By